Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrarenal tacrolimus concentration and renal interstitial fibrosis after kidney transplantation
2019-002539-27Phase 4Terminated
- Sponsor
- Oslo University Hospital
- Start
- Jul 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus in Kidney allograft status (RTx) (3 arms), sponsored by Oslo University Hospital. Primary endpoint: Degree of renal interstitial fibrosis by intrarenal tacrolimus concentration group. Started Jul 2019; status: terminated.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2019-002539-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002539-27.